House GOP Takes Pharma’s Side In Debate Over Aduhelm

By Gabrielle Wanneh / February 10, 2022 at 11:23 AM
House Republicans are taking pharma’s side in the debate over Medicare coverage of the Alzheimer’s drug Aduhelm, and they’ve added a new complaint: that CMS’ proposed policy would exclude people with Down Syndrome. A group of 47 Republicans signed a letter against CMS’ draft national coverage determination that would limit coverage of Aduhelm and other monoclonal antibodies under development to patients in clinical trials. Rep. Cathy McMorris Rodgers (WA), the lead Republican on the Energy & Commerce Committee, brought up...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.